---
title: Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke
date: '2024-09-04'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39231343/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20240905183222&v=2.18.0.post9+e462414
source: N Engl J Med
description: 'CONCLUSIONS: In patients with acute ischemic stroke treated with intravenous
  thrombolysis within 3 hours after symptom onset, adjunctive treatment with intravenous
  argatroban or eptifibatide did not reduce poststroke disability and was associated
  with increased mortality. (Funded by the National Institute of Neurological Disorders
  and Stroke; MOST ClinicalTrials.gov number, ...'
disable_comments: true
---
CONCLUSIONS: In patients with acute ischemic stroke treated with intravenous thrombolysis within 3 hours after symptom onset, adjunctive treatment with intravenous argatroban or eptifibatide did not reduce poststroke disability and was associated with increased mortality. (Funded by the National Institute of Neurological Disorders and Stroke; MOST ClinicalTrials.gov number, ...